These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18690943)

  • 1. Is current drug safety an issue?
    Besag FM
    Curr Drug Saf; 2007 Jan; 2(1):1-4. PubMed ID: 18690943
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenic contact dermatitis and eczematous reactions.
    Angelini G; Vena GA; Grandolfo M; Mastrolonardo M
    Clin Dermatol; 1993; 11(4):467-77. PubMed ID: 8124635
    [No Abstract]   [Full Text] [Related]  

  • 3. [The general principles of drug administration and nursing actions].
    Laganá MT; de Araújo TL; dos Santos LC; da Silva SH
    Rev Esc Enferm USP; 1989 Apr; 23(1):3-16. PubMed ID: 2638499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problems and perils of prescription medicines.
    Richards D
    Expert Opin Drug Saf; 2003 Sep; 2(5):509-11. PubMed ID: 12946251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-related deaths among medical inpatients.
    Porter J; Jick H
    JAMA; 1977 Feb; 237(9):879-81. PubMed ID: 576326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the relationship between a starting dose in first-in-human studies and no observed adverse effect level in nonclinical studies.
    Sato A; Narukawa M
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):770-6. PubMed ID: 25034619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current issues with regard to single dose toxicity studies.
    Hashimoto M
    J Toxicol Sci; 1996 Dec; 21(5):417-20. PubMed ID: 9035048
    [No Abstract]   [Full Text] [Related]  

  • 8. The mathematics of drug dose individualization should be built with random-effects linear models.
    Diaz FJ; de Leon J
    Ther Drug Monit; 2013 Apr; 35(2):276-7. PubMed ID: 23503456
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models".
    Holford NH; Buclin T
    Ther Drug Monit; 2013 Dec; 35(6):873-4. PubMed ID: 24263647
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs with aging. Misperceptions about medications.
    Mayo Clin Health Lett; 2014 Dec; 32(12):7. PubMed ID: 26087529
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug metabolism and metabolite safety assessment in drug discovery and development.
    He C; Wan H
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1071-1085. PubMed ID: 30215280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to drugs and chemicals. A resumé and progress report.
    Irey NS
    JAMA; 1974 Oct; 230(4):596-8. PubMed ID: 4479057
    [No Abstract]   [Full Text] [Related]  

  • 13. Translating the dose response into risk and benefit.
    Warren JB
    Br J Clin Pharmacol; 2019 Oct; 85(10):2187-2193. PubMed ID: 30945324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using technology to enhance measurement of drug-use safety.
    Schneider PJ
    Am J Health Syst Pharm; 2002 Dec; 59(23):2330-2. PubMed ID: 12489374
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug dosing in elderly patients with chronic kidney disease.
    Lassiter J; Bennett WM; Olyaei AJ
    Clin Geriatr Med; 2013 Aug; 29(3):657-705. PubMed ID: 23849014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic disorders.
    Moser RH
    Mil Med; 1970 Aug; 135(8):619-30. PubMed ID: 4991302
    [No Abstract]   [Full Text] [Related]  

  • 17. TOX-RISK: a program for fitting dose-response formulae and extrapolating between species.
    Crouch EA
    Risk Anal; 1989 Dec; 9(4):599-603. PubMed ID: 2608950
    [No Abstract]   [Full Text] [Related]  

  • 18. [CLINICAL CONTROL OF SIDE-EFFECT OF DRUGS].
    GIBINSKI K
    Pol Tyg Lek; 1964 Sep; 19():1305-8. PubMed ID: 14224347
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs.
    Regenthal R; Krueger M; Koeppel C; Preiss R
    J Clin Monit Comput; 1999 Dec; 15(7-8):529-44. PubMed ID: 12578052
    [No Abstract]   [Full Text] [Related]  

  • 20. Ways to minimize adverse drug reactions. Individualized doses and common sense are key.
    Cohen JS
    Postgrad Med; 1999 Sep; 106(3):163-8, 171-2. PubMed ID: 10494273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.